Salvinija Roznyte

About

Staff Writer Salvinija Roznyte is a writer and journalist based in London. She graduated in 2018 with a Bachelor's degree majoring in Writing and Journalism with a minor in Film Studies. She is interested in the way modern medical technology changes and shapes our world.
39 POSTS

/

0 COMMENTS

Articles

UK doctors told to ignore consumer genetic tests

Royal College of General Practitioners guidance places significant doubt on consumer genetic testing. Consumer interest in genetic testing has grown in popularity in recent years,...

New study shows rapamycin slows Alzheimer’s

A new study from UT Health San Antonio suggests the drug rapamycin may be able to slow the rate of brain-related blood flow decreases. The...

Human Longevity, Inc: $30m injection. Challenges?

Trouble in paradise? Or extra funding for new goals in precision health analytics? The abrupt press announcement on the Human Longevity, Inc. website was one...

Ervaxx exits stealth mode with $17.5 million

UK start-up Ervaxx targets 'dark matter' genes to develop cell therapies. After two years in stealth mode, the new UK-based start-up Ervaxx has stepped out of...

3D bioprinting breakthrough in vascular systems

Researchers develop breakthrough in 3D bioprinting blood networks with functioning skin. The field of 3D bioprinting has shown great advancements toward the production of artificial organs...

Insilico’s Dr Alex Zhavoronkov defines Longevity

The “MMA fighter” of Longevity talks business models, AI drug discovery and working with the right investors. Dr Alex Zhavoronkov is the CEO and co-founder...

60 new Biotech and Agetech start-ups to join showcase

Applications open for the Longevity Leaders World Congress start-up showcase. The Longevity sector is in part characterised by the emergence of two exciting classes of...

The Longevity biotech industry is hitting its stride

An exclusive with AgeX Therapeutics CEO Dr Michael West looks at the puzzle of aging. AgeX Therapeutics is an American biotechnology developing novel therapeutics that...

Agetech’s chance to be the new fintech

Inside the UK business community’s mission to become a leader in Agetech. UK business leaders gathered in the City yesterday to discuss the development of...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.